Proteinuria Treatment Market Regulations and Competitive Landscape Outlook to 2026
- Submitted by: pradnya86
- Views: 68
- Category: Other
- Date Submitted: 08/31/2016 03:28 AM
- Pages: 3
- Report this Essay
Proteinuria is also called as albuminuria is a condition in which urine contains abnormal (excessive) amount of protein. It is a disease which results from damage within the kidneys. The kidney performs filtration of waste, minerals and fluids from the blood to the urine. When kidneys do not perform filtration properly that results an abnormal (excessive) amount of proteins (albumin and globulin) excrete through the urine. Sign and symptom of proteinuria includes edema present in face, arms, hands, abdomen and hypertension with foamy urine. Risk factors for proteinuria includes, diabetes and hypertension (high blood pressure) mostly and sometimes obesity and age over 65.
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market. Kidney disease often has no early symptoms. Hence, lack of awareness among people about proteinuria is expected to restrain the growth of global proteinuria treatment market.
Proteinuria Treatment Market: Drivers and Restraints
Types of proteinuria includes Transient and Orthostatic proteinuria. Proteinuria can be caused by diseases not involving the kidneys, such as multiple myeloma, a cancer of the plasma cells in the bone marrow. In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years. Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure and is another potential cause of protein in the urine.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1486
Proteinuria Treatment Market: Segmentation
Proteinuria treatment market can be segmented on the basis of drug type, distribution channel and geography.
Based on drug type, proteinuria treatment market can be segmented as follows:
ACE inhibitors...
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market. Kidney disease often has no early symptoms. Hence, lack of awareness among people about proteinuria is expected to restrain the growth of global proteinuria treatment market.
Proteinuria Treatment Market: Drivers and Restraints
Types of proteinuria includes Transient and Orthostatic proteinuria. Proteinuria can be caused by diseases not involving the kidneys, such as multiple myeloma, a cancer of the plasma cells in the bone marrow. In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years. Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure and is another potential cause of protein in the urine.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1486
Proteinuria Treatment Market: Segmentation
Proteinuria treatment market can be segmented on the basis of drug type, distribution channel and geography.
Based on drug type, proteinuria treatment market can be segmented as follows:
ACE inhibitors...